S2: Sensitivity analysis result
Study / OR (95% CI) / p valueMa [1] / 1.594 (1.094-2.324) / 0.015
Bayram [2] / 1.691 (1.225-2.335) / 0.001
Borges [3] / 1.607 (1.153-2.240) / 0.005
Kawata [4] / 1.587 (1.118-2.254) / 0.0010
Upadhyay [5] / 1.535 (1.092-2.159) / 0.014
Theodoropoulos [6] / 1.574 (1.118-2.215) / 0.009
Yang [7] / 1.612 (1.141-2.277) / 0.007
Wang [8] / 1.470 (1.073-2.104) / 0.016
Gazouli [9] / 1.506 (1.075-2.109) / 0.017
Yang [10] / 1.687 (1.216-2.340) / 0.002
Jang [11] / 1.659 (1.182-2.328) / 0.003
Borbely [12] / 1.661 (1.197-2.304) / 0.002
Cheng [13] / 1.445 (1.084-1.925) / 0.012
1. Ma F, Zhang H, Zhai Y, Huang W, Zhao C, Ou S, Zhou H, Yuan W, Wang Z, Wang H, Yue W, Yu L, Li P, Xia X, Cai M, Zhang Y, Cui Y, He F, Ma Y, Zhou G (2011) Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese. PLoS One 6 (2):e16748. doi:10.1371/journal.pone.0016748
2. Bayram S, Akkiz H, Bekar A, Akgollu E (2011) The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population. Cancer Epidemiol. doi:S1877-7821(11)00005-1 [pii] 10.1016/j.canep.2011.01.004
3. Borges BD, Burbano RR, Harada ML (2010) Survivin -31C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med. doi:10.1007/s10238-010-0122-5
4. Kawata N, Tsuchiya N, Horikawa Y, Inoue T, Tsuruta H, Maita S, Sato S, Mitobe Y, Narita S, Habuchi T (2010) Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility. Int J Cancer. doi:10.1002/ijc.25850
5. Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B (2010) Role of Survivin Gene Promoter Polymorphism (-31G>C) in Susceptibility and Survival of Esophageal Cancer in Northern India. Ann Surg Oncol. doi:10.1245/s10434-010-1371-y
6. Theodoropoulos GE, Michalopoulos NV, Panoussopoulos SG, Taka S, Gazouli M (2010) Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas 39 (7):976-980. doi:10.1097/MPA.0b013e3181d705d4
7. Bae GU, Yang YJ, Jiang G, Hong M, Lee HJ, Tessier-Lavigne M, Kang JS, Krauss RS (2009) Neogenin regulates skeletal myofiber size and focal adhesion kinase and extracellular signal-regulated kinase activities in vivo and in vitro. Mol Biol Cell 20 (23):4920-4931. doi:E09-06-0491 [pii] 10.1091/mbc.E09-06-0491
8. Wang YH, Chiou HY, Lin CT, Hsieh HY, Wu CC, Hsu CD, Shen CH (2009) Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Urology 73 (3):670-674. doi:S0090-4295(08)01675-0 [pii] 10.1016/j.urology.2008.09.048
9. Gazouli M, Tzanakis N, Rallis G, Theodoropoulos G, Papaconstantinou I, Kostakis A, Anagnou NP, Nikiteas N (2009) Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis 24 (2):145-150. doi:10.1007/s00384-008-0601-2
10. Yang L, Zhu H, Zhou B, Gu H, Yan H, Tang N, Dong H, Sun Q, Cong R, Chen G, Wang B (2009) The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci 54 (5):1021-1028. doi:10.1007/s10620-008-0441-5
11. Jang JS, Kim KM, Kang KH, Choi JE, Lee WK, Kim CH, Kang YM, Kam S, Kim IS, Jun JE, Jung TH, Park JY (2008) Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60 (1):31-39. doi:S0169-5002(07)00555-7 [pii] 10.1016/j.lungcan.2007.09.008
12. Borbely AA, Murvai M, Szarka K, Konya J, Gergely L, Hernadi Z, Veress G (2007) Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol 60 (3):303-306. doi:jcp.2006.037804 [pii] 10.1136/jcp.2006.037804
13. Cheng ZJ, Hu LH, Huang SJ (2008) [Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma]. Ai Zheng 27 (3):258-263. doi:1000-467X200803258 [pii]